The rise of GLP-1 weight-loss medications, such as Wegovy and Mounjaro, is significantly altering shopping habits among users in the UK and US. Many individuals are not only losing weight but also changing their clothing preferences, leading to increased spending on apparel and related products. Reports indicate that as users slim down, they are more inclined to purchase new clothes, skincare, and fitness items.
With the introduction of oral GLP-1 medications in the UK, demand is expected to grow further. Analysts predict that this trend could boost the clothing market by 1% annually over the next three years, particularly benefiting mid-market retailers while impacting plus-size fashion sales negatively.
As GLP-1 medications gain traction, watch for shifts in fashion marketing strategies targeting newly confident consumers. Retailers may need to adapt inventory to cater to changing body sizes and preferences, while plus-size brands could face ongoing challenges.